David A Duffield Trust reports multiple 10b5-1 sales
David A Duffield Trust U/T/A 7/14/88 reported multiple 10b5-1 sales of company common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
David A Duffield Trust U/T/A 7/14/88 reported multiple 10b5-1 sales of company common stock. The filing lists repeated 10b5-1 sales of 107,500 shares with trade dates in March 2026 and a sale of 82,884 shares on 01/08/2026. Reported proceeds for individual trades are shown as $13,797,431.50 to $15,824,248.50 in the excerpt.
Insights
Routine 10b5-1 sales by an affiliated trust; filing documents executed dispositions.
The entries reflect scheduled dispositions under a 10b5-1 plan attributed to the David A Duffield Trust. Each row shows trade date, share count, and gross proceeds for the trade.
Timing and amounts are explicit in the excerpt; cash‑flow recipients and whether the plan is continuing are not detailed in this excerpt.
Key Figures
Key Terms
10b5-1 regulatory
Private Placement financial
Form 144 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did the WDAY filing disclose about the David A Duffield Trust sales?
Do the entries show proceeds for each David A Duffield Trust trade in the WDAY filing?
Were the WDAY dispositions described as private placements or public sales?
AI-generated analysis. How Rhea-AI works. Not financial advice.